Jerzy Gruhn

Corporate Officer/Principal bij European Association For The Study of Diabetes

Health Technology

Consumer Services

Actieve functies van Jerzy Gruhn

Bedrijven	Functie	Begin	Einde
European Association For The Study of Diabetes	Corporate Officer/Principal	-	-

Bedrijven	Functie	Begin	Einde
Novo Nordisk, Inc. Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.	President	01-01-2008	-
Pharmaceutical Research & Manufacturers of America Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.	Directeur/Bestuurslid	21-12-2010	-
NOVO NORDISK A/S	Corporate Officer/Principal	-	-

University of Warsaw

Graduate Degree

Internationaal

Operationeel

Corporate Officer/Principal	2
President	1
Director/Board Member	1

Sectoraal

Health Technology	4
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
NOVO NORDISK A/S	Health Technology

Bedrijven in privébezit	3
Pharmaceutical Research & Manufacturers of America Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.	Health Technology
Novo Nordisk, Inc. Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.	Health Technology
European Association For The Study of Diabetes